stroke

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 47/100

   Before the bolus: why anti-amyloid therapy must become part of every stroke code

   ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Annals of medicine and surgery (2012) · 2026-08-21 · Treatments

   Anti-amyloid monoclonal antibodies provide disease-modifying treatment options for selected patients with early symptomatic Alzheimer disease, but introduce new challenges for acute stroke care.

   • Treatments
   • Side Effects
2. 55/100

   Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden

   ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Frontiers in aging neuroscience · 2023-07-14 · Biomarkers

   The disease course of arteriolosclerosis CSVD may be related to cognitive function and total MRI burden.

   • Brain Scans
3. 40/100

   Cognitive impairment and stroke in elderly patients

   ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Vascular health and risk management · 2016-03-24 · Drug development

   We reviewed current knowledge about the interaction between stroke and vascular risk factors and the development of cognitive impairment and dementia.

   • Treatments
   • Risk Factors
4. 36/100

   Genetic factors in cerebral small vessel disease and their impact on stroke and dementia

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2016-01-01 · Genetics

   Cerebral small vessel disease (SVD) is among the most frequent causes of both stroke and dementia.

   • Genetics
5. 47/100

   Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus

   ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of diabetes investigation · 2015-10-03 · Drug development

   Patients with type 2 diabetes mellitus are at risk for accelerated cognitive decline and dementia.

   • Treatments
   • Risk Factors
6. 36/100

   Memantine enhances recovery from stroke

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Stroke · 2014-06-17 · Treatments

   Our results suggest that memantine improves stroke outcomes in an apparently non-neuroprotective manner involving increased brain-derived neurotrophic factor signaling, reduced reactive astrogliosis, and improved vascularization, associated with improved recovery of sensory and motor cortical function.

   • Treatments
7. 36/100

   Antihypertensive treatment can prevent stroke and cognitive decline

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Nature reviews. Neurology · 2012-12-18 · Drug development

   Hypertension is a highly prevalent risk factor for stroke and dementia, and is the greatest risk factor for small-vessel disease-a frequent cause of lacunar infarction and intracerebral haemorrhage.

   • Treatments
   • Prevention
   • Risk Factors
8. 36/100

   Lacunar stroke

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Expert review of neurotherapeutics · 2009-02-01 · Drug development

   Lacunar infarcts or small subcortical infarcts result from occlusion of a single penetrating artery and account for one quarter of cerebral infarctions.

   • Risk Factors
9. 36/100

   Prevention of stroke and dementia with statins: Effects beyond lipid lowering

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The American journal of cardiology · 2003-02-01 · Drug development

   Stroke is a major cause of mortality and morbidity.

   • Treatments
   • Prevention

All topic tags with their study counts